| 000 | 01811 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250517174446.0 | ||
| 264 | 0 | _c20181221 | |
| 008 | 201812s 0 0 eng d | ||
| 022 | _a1029-2403 | ||
| 024 | 7 |
_a10.1080/10428194.2017.1376745 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKamran, Sophia C | |
| 245 | 0 | 0 |
_aClinical outcome of patients with early stage favorable Hodgkin lymphoma treated with ABVD × two cycles followed by FDG-PET/CT restaging and 20 Gy of involved-site radiotherapy. _h[electronic resource] |
| 260 |
_bLeukemia & lymphoma _c06 2018 |
||
| 300 |
_a1384-1390 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects |
| 650 | 0 | 4 |
_aBleomycin _xadverse effects |
| 650 | 0 | 4 | _aChemoradiotherapy |
| 650 | 0 | 4 |
_aDacarbazine _xadverse effects |
| 650 | 0 | 4 |
_aDoxorubicin _xadverse effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFluorodeoxyglucose F18 |
| 650 | 0 | 4 |
_aHodgkin Disease _xdiagnosis |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIn Vivo Dosimetry |
| 650 | 0 | 4 | _aKaplan-Meier Estimate |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aNeoplasm Staging |
| 650 | 0 | 4 | _aPositron Emission Tomography Computed Tomography |
| 650 | 0 | 4 | _aRadiation Dosage |
| 650 | 0 | 4 |
_aRadiotherapy, Adjuvant _xmethods |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aVinblastine _xadverse effects |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aJacene, Heather A | |
| 700 | 1 | _aChen, Yu-Hui | |
| 700 | 1 | _aMauch, Peter M | |
| 700 | 1 | _aNg, Andrea K | |
| 773 | 0 |
_tLeukemia & lymphoma _gvol. 59 _gno. 6 _gp. 1384-1390 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1080/10428194.2017.1376745 _zAvailable from publisher's website |
| 999 |
_c27591632 _d27591632 |
||